מדיקינט MR כמוסות בשחרור מושהה 40 מ"ג

Country: Iżrael

Lingwa: Ebrajk

Sors: Ministry of Health

Ingredjent attiv:

METHYLPHENIDATE HYDROCHLORIDE 40 MG

Disponibbli minn:

MEDILINE LTD.

Kodiċi ATC:

N06BA04

Għamla farmaċewtika:

MODIFIED RELEASE CAPSULES

Rotta amministrattiva:

PER OS

Manifatturat minn:

MEDICE ARZNEIMITTEL PUETTER GMBH & CO.KG, GERMANY

Grupp terapewtiku:

METHYLPHENIDATE

Indikazzjonijiet terapewtiċi:

Medikinet Modified Release Capsules are indicated as part of a comprehensive treatment program for attention-deficit/hyperactivity disorder (ADHD) in children over 6 years of age when remedial measures alone prove insufficient. Treatment must be under the supervision of a specialist in childhood behavioural disorders. Diagnosis should be made according to DSM-IV criteria or the guidelines in ICD-10.

Data ta 'l-awtorizzazzjoni:

2011-05-01